Widespread vitiligo and poliosis following ipilimumab-nivolumab combination therapy.

Khashayar Nemovi Arsia JamaliKeyan MatinpourConstantin A Dasanu

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

We report a unique case of severe vitiligo and poliosis that involved total body surface area in a Caucasian man with dark complexion, resembling albinism. Further studies are warranted to evaluate the severity of dermatologic side effects with combination immune checkpoint inhibitor therapy.

Keyphrases

combination therapy
early onset
african american
case control
stem cells
mesenchymal stem cells